↓ Skip to main content

Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion

Overview of attention for article published in BMC Cancer, September 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
15 Mendeley